Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000460097 | SCV000544492 | likely benign | Tuberous sclerosis 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256248 | SCV002531038 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-11-19 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002256248 | SCV002727008 | likely benign | Hereditary cancer-predisposing syndrome | 2022-01-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003153598 | SCV003843709 | likely pathogenic | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003320645 | SCV004025845 | uncertain significance | not provided | 2023-02-14 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in a patient with clinically suspected tuberous sclerosis (Meng et al., 2021); This variant is associated with the following publications: (PMID: 32917966) |